Global Pharmaceutical Quality Control Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2022 –2029 |
 Marktgröße (Basisjahr) | USD 6.53 Billion |
 Marktgröße (Prognosejahr) | USD 16.75 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
Global Pharmaceutical Quality Control Market, By Product (Consumables, Instruments, Services), Analysis Type (Sterility Testing, Bio burden Testing, Endotoxin Testing, Stability Testing, Extractable and Leachable Testing, Raw Material Testing), Products Tested (Vaccines, Plasma Product, Drugs) – Industry Trends and Forecast to 2030.
Pharmaceutical Quality Control Market Analysis and Size
Technical issues are the key factors that restrain the growth of the pharmaceutical quality control market. However, complicated and time-consuming regulatory policies act as a challenge for the growth of the pharmaceutical quality control market. Another impactful reason for the increased pharmaceutical quality control market has been the increased innovations and advancements of technologies provided by the different market players currently established, they are focused on constant upgradations of technologies to improve the quality of healthcare being provided to the different patients.
Data Bridge Market Research analyses that the pharmaceutical quality control market which was USD 2,316.5 million in 2022, is expected to reach USD 4,866.24 million by 2030, and is expected to undergo a CAGR of 10.23% during the forecast period. “Instruments” dominates the product segment of the pharmaceutical quality control market owing to the expanding market for generic drugs necessitates stringent quality control to ensure bioequivalence and meet regulatory requirements. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pharmaceutical Quality Control Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Consumables, Instruments, Services), Analysis Type (Sterility Testing, Bio burden Testing, Endotoxin Testing, Stability Testing, Extractable and Leachable Testing, Raw Material Testing), Products Tested (Vaccines, Plasma Product, Drugs) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa) |
|
Market Players Covered |
Merck KGaA (Germany), bioMérieux SA (France), Charles River Laboratories International, Inc. (U.S.), Sartorious AG (Germany), WuXi AppTec (China), Thermo Fisher Scientific, Inc. (U.S.), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Toxikon Corporation (U.S.), McKinsey & Company (U.S.), Esco Micro Pte. Ltd (Singapore), Lucideon Limited (U.K.), PerkinElmer Inc. (U.S.), SOLVIAS AG (Switzerland), Shimadzu Scientific Instruments (Japan), METTLER TOLEDO (Switzerland), REMI GROUP (India), BRAM-COR SPA (Italy), Panomex Inc. (India), Waters Corporation (U.S), and Danaher (U.S.) |
|
Market Opportunities |
|
Market Definition
Pharmaceutical quality control refers to the integration of all procedures undertaken to ensure the identity and purity of particular pharmaceutical products. The rise in awareness for quality control of pharmaceuticals products is helping the global pharmaceutical quality control market to grow at a rapid rate. The increase in the development of comprehensive analytical tests drives market growth. The demand for integrated analytical services spanning all stages of drug discovery, development, and manufacturing also drives the market growth to further height.
Pharmaceutical Quality Control Market Dynamics
Drivers
- Stringent Regulatory Requirements
The pharmaceutical industry is subject to strict regulations and quality standards imposed by regulatory bodies worldwide. Compliance with these regulations drives the demand for robust quality control measures
- Increasing Focus on Patient Safety
Patient safety is a critical concern in the pharmaceutical industry. Quality control ensures that drugs are safe, effective, and free from contaminants, ensuring patient well-being and trust in pharmaceutical products
- Growing Generic Drug Market
The expanding market for generic drugs necessitates stringent quality control to ensure bioequivalence and meet regulatory requirements. Quality control plays a crucial role in maintaining the safety and efficacy of generic drug formulations
Opportunities
- Increasing Global Pharmaceutical Production
The growing demand for pharmaceutical products, driven by population growth and rising healthcare needs, presents opportunities for the expansion of quality control services to meet the rising production volumes
- Outsourcing of Quality Control Services
Many pharmaceutical companies outsource their quality control activities to specialized service providers. This trend creates opportunities for contract research organizations (CROs) and third-party laboratories offering quality control services
Restraints
- Cost and Time Constraints
Quality control processes can be time-consuming and costly, involving extensive testing, analysis, and documentation. Balancing the need for stringent quality control with cost and time efficiency poses a challenge for pharmaceutical companies
- Evolving Regulatory Landscape
Regulatory requirements for quality control are constantly evolving, necessitating continuous updates and adherence to new guidelines. Compliance with changing regulations can be challenging and requires ongoing investment in training and infrastructure
Challenges
- Complex Supply Chains
The pharmaceutical industry relies on global supply chains, making quality control challenging due to factors like transportation, storage, and distribution across various regions. Ensuring consistent quality throughout the supply chain is a significant challenge
- Analytical Method Validation
Validating analytical methods used in quality control is crucial for accurate and reliable results. Developing and validating robust methods for complex drug formulations and diverse matrices can be a challenge for pharmaceutical quality control laboratories
This pharmaceutical quality control market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharmaceutical quality control market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Recent Developments
- In July 2020, Liberty General Insurance has launched ‘Critical Connect’ where one can choose from two programs for sum insured ranging from Rs 1 lakh up to Rs. 1crore. If the customer opts for plan A, he or she can choose Critical Illness Bundles Covering 9, 25, or 43 critical illnesses. Whereas, plan B offers disease-specific bundles such as Heart Protect, Cancer Protect, Renoliv Protect, and Brain Protect. With this launch, the company has enhanced its offering to the customers for pharmaceutical quality control
- In November 2022, Nassau Financial Group announced that it entered into a binding agreement with Delaware Life Insurance Company to buy the Delaware Life Insurance Company of New York
Global Pharmaceutical Quality Control Market Scope
The pharmaceutical quality control market is segmented on the basis of product, analysis type, and products tested. The growth amongst these segments will help you analyses meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Product
- Consumable
- Instruments
- Services
Analysis Type
- Sterility Testing
- Membrane Filtration
- Direct Inoculation
- Bio Burden Testing
- Aerobic Count Testing
- Anaerobic Count Testing
- Spore Count Testing
- Fungi/ Mold Count Testing
- Endotoxin Testing
- Stability Testing
- Extractable & Leachable Testing
- Raw Material Testing
Products Tested
- Vaccines
- Plasma Product
- Drugs
Pharmaceutical Quality Control Market Regional Analysis/Insights
The pharmaceutical quality control market is analysed and market size insights and trends are provided by country, product, analysis type, and products tested as referenced above.
The countries covered in the pharmaceutical quality control market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America is likely to lead the global pharmaceutical quality control market. The regional market has been driven by the rising cases of chronic diseases such as cancer and increase in medical expenses in the region. However, the sudden boom in cancer diagnosis and the increasing rate of death is the main factor propelling the growth of the regional market.
Asia-Pacific is expected to witness significant growth during the forecast period from 2023 to 2030 due to due to rise in the demand of health insurance policies in densely populated countries such as India and China.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Pharmaceutical Quality Control Market Share Analysis
The pharmaceutical quality control market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pharmaceutical quality control market.
Some of the major players operating in the pharmaceutical quality control market are
- Merck KGaA (Germany)
- bioMérieux SA (France)
- Charles River Laboratories International, Inc. (U.S.)
- Sartorius AG (Germany)
- WuXi AppTec (China)
- Thermo Fisher Scientific, Inc. (U.S.)
- SGS S.A. (Switzerland)
- Eurofins Scientific (Luxembourg)
- Toxikon Corporation (U.S.)
- McKinsey & Company (U.S.)
- Esco Micro Pte. Ltd (Singapore)
- Lucideon Limited (U.K.)
- PerkinElmer Inc. (U.S.)
- SOLVIAS AG (Switzerland)
- Shimadzu Scientific Instruments (Japan)
- METTLER TOLEDO (Switzerland)
- REMI GROUP (India)
- BRAM-COR SPA (Italy)
- Panomex Inc. (India)
- Waters Corporation (U.S.)
- Danaher (U.S.)
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
